Prescribing information

 

Prescribing information

__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

This selection of resources is designed for healthcare professionals to support patients with relapsing forms of multiple sclerosis (RMS) throughout their KESIMPTA®▼ (ofatumumab) journey.

You can download these materials and share them with your healthcare team and patients.

A guide for healthcare professionals: Getting to know KESPIMTA▼'- INTRODUCTION BOOKLET FOR HEALTHCARE PROFESSIONALS
 

INTRODUCTION BOOKLET FOR HEALTHCARE PROFESSIONALS

This guide is designed to help you explain the content of the PATIENT WELCOME BOOKLET to patients who have been prescribed KESIMPTA.

Download

Image thumbnail of a KESPIMTA▼ document- CLINICAL PROTOCOL FOR GREAT BRITAIN AND NORTHERN IRELAND
 

CLINICAL PROTOCOL FOR GREAT BRITAIN AND NORTHERN IRELAND

A document providing a template and useful information to support the development of your local clinical protocol for treatment with KESIMPTA.

Registration is required to access this resource.

Download

Image thumbnail 'Sensoready pen healthcare professional instructions'- KESIMPTA DEMONSTRATION PEN KIT
 

KESIMPTA DEMONSTRATION PEN KIT

A self-injection demonstration kit is available to help show patients how to use the injection pen correctly. To obtain a demonstration kit, please contact Novartis directly or get in touch with your local Novartis representative.

Download GB version

Download NI version

 

Image thumbnail 'Welcome to KESPIMTA▼'- PATIENT DISCUSSION GUIDE
 

PATIENT DISCUSSION GUIDE

In a presentation format, this guide helps you lead an introductory discussion with your patients who have been prescribed KESIMPTA.

Download

Image thumbnail of a document- GP LETTER
 

GP LETTER

A letter template that can be sent to your patient’s GP explaining the prescription for KESIMPTA and important information on its appropriate use.

Download

Image thumbnail of a document- TREATMENT INITIATION CHECKLIST
 

TREATMENT INITIATION CHECKLIST

A checklist to follow for the initiation of treatment with KESIMPTA, from pre-prescription contraindication checks through to administration of the first dose.

Download GB version

Download NI version

 

Thumbnail of KESIMPTA Switch Tool
 

KESIMPTA SWITCH TOOL

The KESIMPTA switch tool provides guidance on how to switch patients to KESIMPTA from other treatments.

Registration is required to access this resource.

View

 

Image thumbnail 'Getting to know KESPIMTA▼'- PATIENT WELCOME BOOKLET
 

PATIENT WELCOME BOOKLET

A useful booklet for patients prescribed KESIMPTA. It explains about how KESIMPTA works, potential side effects, maintaining well-being and includes an injection diary for patients to record their treatment progress.

Download

 
Rate this content: 
No votes yet
UK | December 2021 | 174498
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]